嵌合抗原受体-T细胞治疗儿童肿瘤的临床研究进展
Progress in clinical studies of chimeric antigen receptor engineered T cells for treatment of childhood cancer
DOI: 10.7499/j.issn.1008-8830.2017.11.018
Keywords: 嵌合抗原受体,肿瘤,白血病,免疫治疗,儿童,
Chimeric antigen receptor,Cancer,Leukemia,Immunotherapy,Child
Abstract:
Full-Text